First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+ breast cancer patients 06/04/2018 Health Problems
First approved medication for tardive dyskinesia demonstrates safety, study shows 04/30/2018 Health Problems
First ever risk tool predicts readmission rates for patients after undergoing TAVR 04/27/2018 Health Problems